Publicaciones (79) Publicaciones de FELIPE COUÑAGO LORENZO

2024

  1. Docetaxel Provides Oncological Benefits in the Era of New-Generation Androgen Receptor Inhibitors - or Is Three a Crowd?

    Clinical Genitourinary Cancer, Vol. 22, Núm. 1, pp. 56-66

  2. Hypofractionated whole breast IMRT with HDR brachytherapy boost in early-stage breast cancer: Long-term results from a single-center

    Brachytherapy

  3. Is trimodal therapy the current standard for muscle-invasive bladder cancer?

    Actas Urologicas Espanolas

2023

  1. Clinical Usefulness of Prostate-specific Membrane Antigen-ligand Positron Emission Tomography/Computed Tomography for the Detection of Prostate Cancer Biochemical Recurrence after Primary Radiation Therapy in Patients with Prostate-specific Antigen Below the Phoenix Threshold: Systematic Review and Meta-analysis

    Clinical Oncology, Vol. 35, Núm. 12, pp. e676-e688

  2. Coronavirus disease 2019 and lung cancer: where are we?

    Exploration of Targeted Anti-tumor Therapy, Vol. 4, Núm. 5, pp. 1082-1094

  3. Jorge clinical study: 10-year outcomes of risk-adapted radiotherapy defined by multiparametric MRI for prostate cancer

    World Journal of Urology, Vol. 41, Núm. 12, pp. 3829-3838

  4. Necessity of Pelvic Lymph Node Irradiation in Patients with Recurrent Prostate Cancer after Radical Prostatectomy in the PSMA PET/CT Era: A Narrative Review

    Biomedicines, Vol. 11, Núm. 1

  5. Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Prognostic Factors in Locally Advanced Rectal Cancer

    Oncology (Switzerland), Vol. 101, Núm. 6, pp. 349-357

  6. Novel Approaches in the Systemic Management of High-Risk Prostate Cancer

    Clinical Genitourinary Cancer, Vol. 21, Núm. 6, pp. e485-e494

  7. Oligometastatic Hormone-Sensitive Prostate Cancer. Why Radiotherapy?

    Clinical Genitourinary Cancer, Vol. 21, Núm. 3, pp. e93-e103

  8. PSMA PET/CT imaging for biochemical recurrence of prostate cancer after radiotherapy: is it necessary to review the Phoenix criteria?

    Clinical and Translational Imaging, Vol. 11, Núm. 3, pp. 241-254

  9. Prostate Cancer: Management of Biochemical Recurrence after Surgery

    Archivos espanoles de urologia, Vol. 76, Núm. 10, pp. 733-745

  10. Radiogenomics in lung cancer: Where are we?

    Lung Cancer, Vol. 176, pp. 56-74

  11. Radioterapia en etapas precoces del cáncer de pulmón

    Revisiones en Cancer, Vol. 37, Núm. 3, pp. 133-147

  12. Role of Radiotherapy and Hormone Therapy in Patients with Node-Positive Locally Advanced Prostate Cancer

    Archivos espanoles de urologia, Vol. 76, Núm. 10, pp. 718-732

  13. Stereotactic Body Radiotherapy for Kidney Cancer: Ready for Prime Time?

    Clinical Oncology, Vol. 35, Núm. 3, pp. 163-176

  14. Stereotactic body radiation therapy (SBRT): a new treatment option in renal cancer

    Actas Urologicas Espanolas

  15. Stereotactic body radiation therapy after radical prostatectomy: current status and future directions

    World Journal of Urology, Vol. 41, Núm. 11, pp. 3333-3344

  16. Stereotactic body radiation therapy for kidney cancer. Where do we stand?

    International Journal of Urology, Vol. 30, Núm. 5, pp. 437-445

  17. Total neoadjuvant therapy for locally advanced rectal cancer: a narrative review

    Future oncology (London, England), Vol. 19, Núm. 25, pp. 1753-1768